PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Hupperts, Raymond
TI  - PR—Fampridine Improves Mobility in Patients with MS
DP  - 2014 Jul 01
TA  - MD Conference Express
PG  - 17--17
VI  - 14
IP  - 29
4099  - http://mdc.sagepub.com/content/14/29/17.1.short
4100  - http://mdc.sagepub.com/content/14/29/17.1.full
AB  - Prolonged release (PR)-fampridine treatment resulted in sustained and clinically meaningful improvement in walking ability and balance throughout a 6-month treatment period in individuals with multiple sclerosis (MS). The Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis study [MOBILE; NCT01597297; Hupperts R et al. ACTRIMS/ECTRIMS 2014 (poster P922)] evaluated the effect of PR-fampridine on walking ability, dynamic and static balance, and subjective impressions of well-being.